Vaccentis
LATE STAGE DEVELOPMENT OF AN PROTEIN-BASED TUMOUR VACCINE FOR RENAL CELL CARCINOMA VCC MEDICAL DIVISION IS DEVELOPING CLINICALLY PROVEN PRODUCTS, SHOWN TO MAINTAIN REMISSION AND ALLEVIATE DISEASE VCC-001 cancer vaccine Phase data in Renal Cell Cancer has demonstrated clinical effect and was well tolerated, a disease with few current treatment options VCC-001 cancer vaccine platform has significant potential in metastatic renal cell, colon and pancreatic cancers
7-day free trial · no credit card
Verified contacts
5
available on Kipplo
LinkedIn employees
7
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 5 verified contacts at Vaccentis
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
5 contacts with verified email or phone · masked until revealed.
- MM
Martin Munte
(Ä) · Other
EmailPhone - SR
Subhasis Roy
Board Member · General Business & Management
EmailPhone
Showing 2 of 5 verified contacts
Top roles at Vaccentis
3 distinct titles indexed · top 3 shown.
- 1(ä)
- 1board member
- 1senior project manager
Sign up to unlock all 5 contacts at Vaccentis
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 5 verified contacts at Vaccentis
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.